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Abstract
Background: HIWI, the human homologue of Piwi family, is present in CD34+ hematopoietic
stem cells and germ cells, but not in well-differentiated cell populations, indicating that HIWI may
play an impotent role in determining or maintaining stemness of these cells. That HIWI expression
has been detected in several type tumours may suggest its association with clinical outcome in
cancer patients.
Methods:  With the methods of real-time PCR, western blot, immunocytochemistry and
immunohistochemistry, the expression of HIWI in three esophageal squamous cancer cell lines
KYSE70, KYSE140 and KYSE450 has been characterized. Then, we investigated HIWI expression
in a series of 153 esophageal squamous cell carcinomas using immunohistochemistry and explored
its association with clinicopathological features.
Results: The expression of HIWI was observed in tumour cell nuclei or/and cytoplasm in 137
(89.5%) cases, 16 (10.5%) cases were negative in both nuclei and cytoplasm. 86 (56.2%) were
strongly positive in cytoplasm, while 49 (32.0%) were strongly positive in nuclei. The expression
level of HIWI in cytoplasm of esophageal cancer cells was significantly associated with histological
grade (P = 0.011), T stage (P = 0.035), and clinic outcome (P < 0.001), while there was no
correlation between the nuclear HIWI expression and clinicopathological features.
Conclusion: The expression of HIWI in the cytoplasm of esophageal cancer cells is significantly
associated with higher histological grade, clinical stage and poorer clinical outcome, indicating its
possible involvement in cancer development.
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Background
Cancer therapeutics has experienced remarkable improve-
ment, but still, cancer is a leading cause of death world-
wide. During the past 7 years, cells with stem cell-like
features so-called cancer stem cells have been identified in
acute myeloic leukemia, breast cancer, melanoma and
tumors of central nervous system, etc[1,2], which support
the concept that cancer stem cells are essential to the
development and perpetuation of human cancer [3-5]. It
has been suggested that deregulation of stem cell self-
renewal may cause development of malignancies because
cancer cells and stem cells share several similarities, such
as the ability of self-renewal without loss of proliferation
capacity, relative resistance to drugs, radiation, and apop-
tosis. In addition, cancer stem cells have been shown to
express typical markers of normal stem cells [2]. These
similarities suggest the expression of genes determining
cell renewal and stemness in cancer cells.
HIWI, also called PIWI1, is a human homologue of the
PIWI family. The PIWI family, a subfamily of Argonaute
proteins, have so far been described in jellyfish,
Caenorhabditis elegans, zebrafish, drosophila, mice as well
as many other species [6-12]. The PIWI family are highly
conserved during evolution and play an important role in
stem cell self-renewal, division, gametogenesis, germ cell
proliferation, RNA silencing and translational regulation
in diverse organisms [13-17]. The impressive biological
capacities of PIWI family suggest that they may be key ele-
ments in the regulation of stem cells and germ cells.
As a human member of PIWI family, HIWI is present in
CD34+ hematopoietic stem cells but not in well-differen-
tiated cell populations, indicating that HIWI may be a
candidate protein in determination or regulation of HSC
development[18]. Qiao et al[19] found that HIWI was
also expressed in spermatocytes and round spermatids
during spermatogenesis and increased in testicular semi-
noma, suggesting that deregulation of HIWI expression
may contribute to the occurrence and development of
tumour. Furthermore, HIWI expression has been reported
in different solid tumours such as gastric carcinoma, soft-
tissue sarcoma (STS) and pancreas adenocarcinoma
[16,19-21]. Thus, HIWI may be present in other types of
cancer cells and involved in the development of various
cancer forms.
Esophageal squamous cell carcinoma (ESCC) is one of the
leading causes of cancer-related death throughout the
world and the incidence of which ranks fourth as cause of
death in China and seventh in the world[22]. Although
surgery is potential curative for early stage esophageal can-
cer, it is still a limited clinical option for most patients pre-
senting with advanced disease. Analysis of the stem cell-
associated gene in this malignancy may provide impor-
tant clues to the understanding of this disease develop-
ment.
In the present study, we investigated the expression of
HIWI in a cohort of 153 patients with ESCC and explored
its clinicopathological and survival associations. We did
find that the expression of HIWI was significantly associ-
ated with higher T stage, higher histological grade and
poorer clinical survival, indicating that this protein may
exert positively influence on tumour cell stemness, which




In this retrospective study which was approved by the Eth-
ics Committee of Anyang Tumour Hospital and Anyang
Hygiene Bureau, we randomly selected 153 consecutive
ESCC patients who underwent potentially curative sur-
gery without preoperative chemotherapy or radiotherapy
during the period of 1989-1994 at The Anyang Tumour
Hospital, Henan, China. Among them, 93 are men and 60
are women, ranging from 33-73 years of age with a mean
age of 56.4 years. According to International Union
against Cancer (UICC) 2003 standard, 100 cases were
classified as stage I or II and 53 cases as stage III or IV. The
patients' information and tumour parameters are listed in
Table 1. All the patients were followed at the Anyang
Tumour Hospital until May 2004 supported by an inter-
national collaboration project between Anyang Tumour
Hospital and The Norwegian Radium Hospital[23]. A
total of 97 (63.4%) patients died during the follow-up
period. In addition, 10 "non-cancerous" surrounding
esophageal epithelium specimens were also applied for
the HIWI immunostaining. Surgically removed specimens
were routinely fixed in buffered formalin and embedded
in paraffin block for clinical diagnosis and reclassification
for this study.
The human ESCC cell lines KYSE70, KYSE140 and
KYSE450 (DSMZ, Germany) were cultured in RPMI 1640
medium supplemented with 10% fetal bovine serum at
37°C under 5% CO2 and saturated moisture. The sample
cells were collected and counted by trypan blue exclusion
using a hemocytometer.
Immunocytochemistry
Immunocytochemistry was performed on these three cell
lines. Simply, the cultured cells were detached and the cell
suspension was centrifuged at 2000 rpm for 10 min. The
supernatant was removed before the sediment was mixed
with 2-3 drops plasma and 2 drops thrombin for 1 min.
4% buffered formalin was then added to the coagulated
cell mass, which was then fixed for 30 min and placed in
linen paper for further conventional paraffin cytoblockBMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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preparation. 4 μm sections were cut from the paraffin-
embedded cytoblocks and immunostained according to
the same procedure as tissue blocks described below.
Tissue Arrays
Multitissue array blocks were made with the MTA-1 man-
ual tissue arrayer (Beecher Instruments Inc., Sun Prairie,
WI, USA). Simply, 4 μm sections from the routinely made
paraffin blocks were stained with H&E and re-evaluated to
confirm the diagnosis and to identify three representative
tumour areas. Then, the related paraffin blocks were sub-
sequently oriented and marked. From these blocks, tissue
cores with a diameter of 0.6 mm were punched and
arrayed in triplicate on a recipient paraffin block. After the
block construction was completed, the block was placed
into a 40°C oven overnight for tightening the cylinders by
slightly melting paraffin. 4 μm sections of these tissue
array blocks were cut and placed on charged Super-Frost
Plus glass slides, and dried at 60°C oven for 2-4 hours.
These sections were used for immunohistochemical anal-
ysis. For those samples their tissue array materials were
not representative or not available, the paraffin-embed-
ded conventional sections were used for additional
immunohistochemistry analyses as well.
Immunohistochemistry
Immunohistochemical analysis for HIWI was performed
on 4 μm sections. The Envision Plus detection system
(Dako, Carpinteria, CA, USA) was used for the detection
of immunostaining. The sections were deparaffinized in
Table 1: Clinicopathological features and HIWI expression in esophageal squamous cell carcinoma
Parameters Cases (%) Cytoplasma Nucleus Cytoplasma and Nucleus
Low High P Low High P Low Moderate High P
Age 0.683 0.830 0.727
<51 48 (31.4) 21 27 31 17 13 26 9
51-60 52 (34.0) 25 27 36 16 19 23 10
>60 53 (34.6) 21 32 37 16 14 30 9
Gender 0.448 0.666 0.251
Male 93 (60.8) 43 50 62 31 31 43 19
Female 60 (39.2) 24 36 42 18 15 36 9
Location 0.813 0.311 0.556
Upper 14 (9.2) 5 9 7 7 3 6 5
Middle 101 (66.0) 44 57 71 30 31 53 17
Lower 35 (22.9) 16 19 24 11 11 18 6
Missing 3 (2.0) 2 1 2 1 1 2 0
Size 0.778 0.881 0.705
<31 mm 25 (16.3) 11 14 18 7 7 15 3
31-60 mm 105 (68.6) 48 57 73 32 34 53 18
>60 mm 14 (9.2) 5 9 9 5 4 6 4
Missing 9 (5.9) 3 6 4 5 1 5 3
Lymph node metastasis 0.904 0.232 0.593
- 99 (64.7) 43 56 64 35 27 53 19
+ 54 (35.3) 24 30 40 14 19 26 9
UICC stage 0.074 0.148 0.662
I 0 00 00 0 0 0
II 100 (65.4) 49 51 64 36 32 49 19
III 53 (34.6) 18 35 40 13 14 30 9
IV 0 0 0 0 0 0 0 0
T stage 0.035* 0.278 0.002*
I5  ( 3 . 3 ) 4 14 1 3 2 0
II 39 (25.5) 23 16 31 8 19 16 4
III 100 (65.4) 37 63 63 37 24 52 24
IV 9 (5.9) 3 6 6 3 0 9
Histological grade 0.011* 0.352 0.126
Well 53 (34.6) 31 22 37 16 21 26 6
Moderate 60 (39.2) 25 35 37 23 17 28 15
Poor 40 (26.1) 11 29 30 10 8 25 7
Patients at follow-up <0.001* 0.981 0.001*
Alive 56 (36.6) 35 21 38 18 27 19 10
Dead 97 (63.4) 32 65 66 31 19 60 18
* P < 0.05BMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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xylene and then microwaved in 10 mM citrate buffer (pH
6.0) to unmask the epitopes. Endogenous peroxidase
activity was blocked by incubation with 0.03% hydrogen
peroxide in methanol for 5 min. Sections were incubated
with a monoclonal mouse anti-HIWI antibody (devel-
oped at the Professor Chengchao Shou's lab) for 30 min
at room temperature. The specificity for the HIWI anti-
body was previously reported and the working condition
applied in this study was the same as previously pub-
lished[16]. After gently rinsed three times with washing
buffer, the sections were incubated with the peroxidase-
labeled polymer conjugated to goat anti-mouse IgG
(Dako, Carpinteria, CA, USA) for 30 min before stained
for 5 min with 3'3-diaminobenzidine tetrahydrochloride
(DAB), counterstained by hematoxylin, dehydrated, and
mounted in Diatex. A known HIWI positive seminoma
was used as positive control while the same concentration
of non-immune mouse IgG was applied as negative con-
trol. All controls gave satisfactory results.
HIWI immunostaining scoring
Tumor cell immunoreactivity was scored according to
both nuclear and cytoplasmic staining. Both the extent of
staining (percentage of positive cells) and the intensity of
the reaction were taken into account. Briefly, the extent of
positivity was scored as 0 when no positive cell was
observed; 1 when the percentage of positive cells was
<10%; 2 when it was 10-50%; and 3 when it was >50%.
The intensity was scored as 0 when no positive cells iden-
tified; 1, weak; 2, moderate; and 3, strong staining. Multi-
plying the extent by intensity gave the following
immunohistochemical staining grades as 0, 1, 2, 3, 4, 6
and 9. For statistical analyses, the grades 0, 1, 2 and 3 were
considered as no or weakly stained and scored as 0, the
grades 4, 6 and 9 were considered as strongly stained and
scored as 1. Then all the specimens were attributed to
three groups: "low", both nuclei and cytoplasm were
scored as 0; "moderate", either nuclei or cytoplasm was
scored as 1; "high", both nuclei and cytoplasm were
scored as 1. The evaluation was performed independently
by three experienced investigators who were unaware of
the related clinical information and the conflicting scores
were resolved at a discussion microscope.
Western Blotting Analysis
25 mg of protein samples were separated on a 10% SDS-
acrylamide gel (Bio-Rad) for 1 h at 150 V, and the proteins
were transferred to a nitrocellulose membrane (What-
man, Kent, UK). After blocking in 5% fat-free milk, the
membrane was treated with the dilution of the primary
antibody overnight at 4°C and the dilution of the second-
ary IgG-horseradish peroxidase (HRP) conjugated anti-
body for 1 h at room temperature. The antibodies used for
immunohistochemistry were applied for Western blot-
ting. All the antibodies were diluted in phosphate buff-
ered saline containing 5% Blotto and 0.1% Tween-20. The
stained membranes were visualized by enhanced chemi-
luminescence reaction using the ECL Plus (GE Healthcare,
Fairfild, CT, USA). Western blot experiments were
repeated at least three times on every sample with similar
results.
Statistical Analysis
Bivariate association between ordinal variables was
assessed using Spearman's correlation (exact version). For
categorical data, Pearson's χ2 test was used. All tests of sta-
tistical significance were two-sided. Overall survival was
calculated from date of diagnosis to the date of death or
May 1st, 2004. Survival curves were plotted according to
the Kaplan-Meier method, and the log-rank test was used
to determine significant differences among groups
(pooled over strata for two groups; pairwise over strata for
three groups). Multivariate analysis according to Cox's
proportional hazards regression model adjusted clinico-
pathological factors (age, gender, tumour location,
tumour size, lymph node metastasis, histological grade,
and T stage) was performed to assess which tumor varia-
bles were independently correlated with overall survival.
Statistical analyses were performed using the SPSS 16.0
package and p < 0.05 was considered as statistically signif-
icant.
Results
Characterization of HIWI in Esophageal cancer Cell Lines
To examine the specificity and working concentration of
anti-HIWI Mab, Western blotting and immunocytochem-
istry analysis were performed on two human esophageal
squamous cell carcinoma cell lines Kyse140, Kyse450. Fig-
ure 1b shows typical 98 KD HIWI bands on Kyse140,
which is in agreement with the NP_004755 HIWI charac-
terization on NCBI. But there was no HIWI expression in
Kyse450 cells. Immunocytochemistry of the cell lines
cytoblock paraffin sections (Figure 1a) gave similar results
as shown by Western blotting, indicating that HIWI
expression varies in cancer cell lines.
Pattern of HIWI Expression in Tumour samples
HIWI immunoreactivity was observed in both nucleus
and cytoplasm (Figure 2). Among the 153 specimens, 37
were negative for cytoplasmic staining and 30 were scored
as 1, 2 or 3, which were classified as either negative or
weakly positive for cytoplasmic immunostaining group
(67 in total, 43.8%). 86 (56.2%) were scored as 4, 6 or 9
and classified as strongly positive group. For nuclear stain-
ing, 78 were negative and 26 were scored as 1, 2 or 3, giv-
ing a total of 104 (68.0%) specimens classified as either
negative or weakly positive group. 49 (32.0%) were
scored as 4, 6 or 9, and classified as strongly positive
group (Table 2). Totally, 46 (30.1%) samples exhibited
negative or weak HIWI expression in both cytoplasm andBMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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nuclei, and were classified as negative/weakly positive
group; 58 cases (37.9%) were only strongly immunoreac-
tive in cytoplasm, and 21 (13.7%) only strongly immuno-
reactive in nuclei, classified as moderate expression group
together; 28 cases (18.3%) showed strong immunoreac-
tivity in both cytoplasm and nuclei, classified as strongly
positive group (Table 1). There was no positive expression
in 10 "non-cancerous" surrounding esophageal epithelial
sections.
Relationship Between HIWI Expression and 
Clinicopathological Features
IHC was employed to investigate the association between
HIWI expression and clinicopathological features in the
153 esophageal squamous cell carcinoma patients (Table
1). The expression level of HIWI in cytoplasm was signifi-
cantly associated with histological grade (P = 0.011) and
T stage (P = 0.035), but not associated with age, gender,
a: Immunocytochemistry of HIWI in Kyse140 and Kyse450 cell lines; b: Western-blot analysis of HIWI in these two cell lines Figure 1
a: Immunocytochemistry of HIWI in Kyse140 and Kyse450 cell lines; b: Western-blot analysis of HIWI in these 
two cell lines. α-Tubulin was set as a loading control.
Table 2: Immunohistochemical staining results for HIWI
Score Cytoplasm Nucleus
n (%) n (%)
0 3 7( 2 4 . 2 )7 8( 5 1 . 0 )
1 1 (0.7) 0 (0.0)
2 5 (3.3) 3 (2.0)
3 2 4( 1 5 . 7 )2 3( 1 5 . 0 )
4 5 (3.3) 5 (3.3)
6 4 1( 2 6 . 8 )2 3( 1 5 . 0 )
9 4 0( 2 6 . 1 )2 1( 1 3 . 7 )
Total 153 (100.0) 153 (100.0)BMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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Immunohistochemistry of HIWI in esophageal squamous cell carcinomas (×200) Figure 2
Immunohistochemistry of HIWI in esophageal squamous cell carcinomas (×200). a-c: Tissue array sections; d-g: 
paraffin-embedded conventional sections. a: Negative; b: Strong cytoplasmic staining; c: Strong staining in both cytoplasm and 
nuclei; d: Strong cytoplasmic staining; e: Strong staining in both cytoplasm and nuclei; f: Strong nuclear staining; g: Strong cyto-
plasmic staining in seminoma (positive control).BMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
Page 7 of 10
(page number not for citation purposes)
tumour location, tumour size, lymph node metastasis and
clinical stage, while there was no correlation between the
expression level of HIWI in nucleus and the same clinico-
pathological features.
Association between HIWI immunoreactivity and Survival
Follow-up information was available for 153 patients for
a period of minimum 10 years. The median follow-up
time for the 56 patients still alive was 124 months (range
118-155 months) and for the remaining 97 patients died
during the follow-up period was 61 months (range 1-139
months). In univariate analysis, patients with low HIWI
expression in tumours had a better overall survival than
patients with tumour showing moderate or high HIWI
expression (p < 0.001, p = 0.014, respectively), while there
was no difference between the moderate expression group
and high expression group (p = 0.592) (Figure 3). Interest-
ingly, patients with high cytoplasmic HIWI expression
tumours had a poorer outcome than that with low cyto-
plasmic expression tumours (p < 0.001) (Figure 4). But we
did not see any correlation between patients' outcome
and the expression level of HIWI in the nuclei of tumour
cells (p = 0.979) (Figure 5).
In multivariate Cox's regression analysis, we detected a
2.247-fold increased risk of tumour-related death for
patients (p = 0.001) whose tumours showed high cyto-
plasmic HIWI expression compared to patients with low
cytoplasmic HIWI expression (Table 3). Still, there was no
significant difference in the risk of tumour-related death
between patients with high nuclear HIWI expression and
low nuclear HIWI expression (p  = 0.397). Thus, HIWI
expression in cytoplasm could be an independent prog-
nostic factor of survival.
Discussion
To date, we are the first to disclose the expression of HIWI
in human esophageal squamous cell carcinoma and its
relation to prognosis. The overexpression of HIWI was
previously detected in seminoma, a type of testicular germ
cell tumour[19]. Liu et al. [16] detected the expression of
HIWI in gastric cancer cell line and gastric cancer tissues,
which showed that the percentage of HIWI positive cells
was dramatically increased from 10% in normal gastric
tissues to 76% in gastric cancers. Moreover, its expression
was associated with the proliferation of gastric cancer
cells. In soft-tissue sarcomas, an increased expression of
HIWI was proved to be correlated to a high risk of tumour
related death[21]. Also in pancreas adenocarcinoma,
alterations in mRNA expression of HIWI were also shown
to be associated with increasing risk of tumour-related
death in male patients[20]. All of these findings suggest
Kaplan-Meier survival curves for esophageal squamous cell carcinoma patients with regard to HIWI protein expression: overall  survival versus HIWI expression in both cytoplasm and nuclei Figure 3
Kaplan-Meier survival curves for esophageal squamous cell carcinoma patients with regard to HIWI protein 
expression: overall survival versus HIWI expression in both cytoplasm and nuclei. Patients with low HIWI expres-
sion tumours showed a better overall survival than patients with moderate or high expression tumours, while there was no dif-
ference between the moderate expression group and high expression group. p values were determined by the log-rank test.BMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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that HIWI may play an important role in development of
various cancers.
Esophageal cancer is one of the most aggressive tumours
and the overall prognosis for esophageal cancer patients is
poor[24]. One of the reasons for the low survival rate is
the tumour's intrinsic resistance to many clinical thera-
pies, especially chemotherapy. Chemotherapy often
removes the bulk of a tumour mass without preventing
tumour recurrence, suggesting the survival of a subset of
cancer stem cells. Recent studies have provided experi-
mental evidence for the concept that human tumour
growth and metastasis may depend on a small portion
cancer stem cells[3].
It has been proposed that HIWI is a key regulator of stem
cell pluripotency by controlling cell self-renewal and dif-
ferentiation[18]. Phenotypically, human preimplantation
embryonic cells resemble cancer cells in many ways, espe-
cially in their ability to grow indefinitely. Both types of
cells undergo deprogramming to a proliferating state and
become immortal, self-renewal, and invasive. It has been
reported that HIWI is expressed in human tumours but
not in normal somatic tissues, in agreement with the
hypothesis that embryonic genes are re-activated in
tumour cells.
In our cohort, the expression of HIWI was detected in
nuclei or/and cytoplasm in 137 (89.5%) of 153 human
esophageal squamous cell carcinoma samples with
immunohistochemistry. 86 (56.2%) were strongly posi-
tive in cytoplasm, while 49 (32.0%) were strongly positive
in nuclei. Only a few reports describing the subcellular
location of HIWI protein in cells are available. In the pre-
vious studies, HIWI was discovered only in cyto-
plasm[16,20]. But in our series, HIWI expression was
observed in both nuclei and cytoplasm, which is consist-
ent with the subcellular location pattern of Piwi expres-
sion in germ cells[7,25,26].
Regarding the clinical outcome, no correlation was
observed between the level of HIWI expression in nucleus
and clinicopathological features, neither was the impact
of HIWI expression in nucleus on tumor-related death.
However, the expression level of HIWI in cytoplasm was
positively associated with histological grade (P = 0.011)
and T stage (P = 0.035) in our present study. Furthermore,
patients with high cytoplasmic HIWI expression tumours
showed a poorer survival than that with low cytoplasmic
expression tumours (P < 0.001). Interestingly, when we
took both cytoplasmic and nuclear expression into con-
sideration, only correlation between expression level and
T stage (P = 0.002) could be observed. Moreover, there
Kaplan-Meier survival curves for esophageal squamous cell carcinoma patients with regard to HIWI protein expression: overall  survival versus HIWI expression in cytoplasm Figure 4
Kaplan-Meier survival curves for esophageal squamous cell carcinoma patients with regard to HIWI protein 
expression: overall survival versus HIWI expression in cytoplasm. Patients with high cytoplasmic HIWI expression 
tumours showed a poorer outcome than that with low cytoplasmic expression tumours. p values were determined by the log-
rank test.BMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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was no significant difference between the survival of the
moderate expression group and high expression group (p
= 0.592). Our findings suggest that, although the expres-
sion of HIWI could be observed in both nucleus and cyto-
plasm, only HIWI in cytoplasm plays a role in the
development of human esophageal squamous cell carci-
noma, because it is significantly associated with poorer
survival of the patients. Till now, little is known about the
biological functions of HIWI, especially about how it
functions in epithelial solid cancer. However, increasing
evidence supports the notion that Piwi proteins serve an
epigenetic role in germline and stem cell maintenance.
Miwi and Ziwi, the murine homologue and zebrafish
homologue of Piwi family, localize intensely in perinu-
clear germline granules[27,28], and in particular, Miwi is
a component of the chromatoid body, a dynamic cyto-
plasmic structure that contacts the nuclear periphery
repeatedly[29]. Furthermore, a fraction of Miwi comi-
grates with polysomes on density gradients, suggestive of
a large cytoplasmic piRNA complex[27]. Thus, it is possi-
ble that HIWI proteins, similar to Piwi proteins in the
cytoplasm, may create complex, which impacts on chro-
Kaplan-Meier survival curves for esophageal squamous cell carcinoma patients with regard to HIWI protein expression: overall  survival versus HIWI expression in nuclei Figure 5
Kaplan-Meier survival curves for esophageal squamous cell carcinoma patients with regard to HIWI protein 
expression: overall survival versus HIWI expression in nuclei. There was no correlation between patients' outcome 
and the expression level of HIWI in nuclei of tumour cells. p values were determined by the log-rank test.
Table 3: Multivariate analysis of death events
Parameters Ratio of risk (RR) 95% CI P
Age 1.057 0.806-1.385 0.689
Gender 1.119 0.709-1.767 0.628
Location 1.170 0.785-1.745 0.441
Size 0.925 0.585-1.462 0.739
Lymph node metastasis 2.280 1.429-3.636 0.001*
T stage 1.885 1.204-2.951 0.006*
Histological grade 3.085 2.242-4.247 <0.001*
HIWI in cytoplasm 2.247 1.375-3.670 0.001*
HIWI in nuclei 1.230 0.761-1.988 0.397
* P < 0.05BMC Cancer 2009, 9:426 http://www.biomedcentral.com/1471-2407/9/426
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matin structure and function during cell division. There-
fore, it merits to further study other HIWI family members
in the human esophageal squamous carcinoma, in order
to better understand their clinical correlations.
Conclusion
In summary, we have demonstrated for the first time that
the stem cell associated gene, HIWI, is expressed in
human esophageal squamous cell carcinoma. The higher
level of HIWI protein expression in cytoplasm of the
esophageal carcinomas cells is significantly associated
with higher histological grade, higher T stage and poorer
overall survival. Our results highly indicate the involve-
ment of HIWI in carcinogenesis and development of
human esophageal squamous cell cancer.
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